Stock News

Macerich Co (MAC) Holder Ulysses Management Has Raised Its Holding; Merit Medical Systems (MMSI) Shareholder Frontier Capital Management Co Trimmed Holding

Joshua Nash increased its stake in Macerich Co (MAC) by 265% based on its latest 2017Q3 regulatory filing with the SEC. Ulysses Management Llc bought 265,000 shares as the company’s stock declined 10.63% while stock markets rallied. The hedge fund run by Joshua Nash held 365,000 shares of the real estate investment trusts company at the end of 2017Q3, valued at $20.06 million, up from 100,000 at the end of the previous reported quarter. Ulysses Management Llc who had been investing in Macerich Co for a number of months, seems to be bullish on the $9.83B market cap company. The stock increased 2.13% or $1.36 during the last trading session, reaching $65.11. About 707,200 shares traded. Macerich Company (NYSE:MAC) has declined 18.62% since January 22, 2017 and is downtrending. It has underperformed by 35.32% the S&P500.

Frontier Capital Management Co Llc decreased its stake in Merit Medical Systems Inc. (MMSI) by 42.62% based on its latest 2017Q3 regulatory filing with the SEC. Frontier Capital Management Co Llc sold 1.17M shares as the company’s stock rose 18.76% with the market. The institutional investor held 1.57 million shares of the health care company at the end of 2017Q3, valued at $66.52 million, down from 2.74 million at the end of the previous reported quarter. Frontier Capital Management Co Llc who had been investing in Merit Medical Systems Inc. for a number of months, seems to be less bullish one the $2.37B market cap company. The stock decreased 1.62% or $0.775 during the last trading session, reaching $47.225. About 137,521 shares traded. Merit Medical Systems, Inc. (NASDAQ:MMSI) has risen 81.84% since January 22, 2017 and is uptrending. It has outperformed by 65.14% the S&P500.

Investors sentiment increased to 0.95 in Q3 2017. Its up 0.17, from 0.78 in 2017Q2. It increased, as 19 investors sold MAC shares while 114 reduced holdings. 39 funds opened positions while 87 raised stakes. 134.98 million shares or 0.62% more from 134.15 million shares in 2017Q2 were reported. 2.05 million are owned by Dimensional Fund L P. Highland Capital LP has invested 0.02% in Macerich Company (NYSE:MAC). Tcw Group has 286,032 shares for 0.12% of their portfolio. Nomura Holdg invested in 9,401 shares or 0% of the stock. Employees Retirement Systems Of Texas has invested 0.07% in Macerich Company (NYSE:MAC). Teacher Retirement Systems Of Texas has 0.01% invested in Macerich Company (NYSE:MAC). Guardian Life Insurance Commerce Of America invested in 0% or 246 shares. Cornerstone Capital Mngmt Holdings Llc reported 0.03% stake. Next Fincl Group accumulated 815 shares or 0.01% of the stock. Quantres Asset Management Ltd invested in 0.28% or 7,800 shares. The California-based Wealthfront has invested 0.01% in Macerich Company (NYSE:MAC). Pacad Ltd holds 2,800 shares. Los Angeles Cap & Equity Research reported 43,331 shares stake. Exane Derivatives reported 0% stake. Cibc Asset Inc holds 0% or 13,195 shares.

Among 21 analysts covering The Macerich Company (NYSE:MAC), 8 have Buy rating, 3 Sell and 10 Hold. Therefore 38% are positive. The Macerich Company had 48 analyst reports since July 21, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, May 30 by Mizuho. RBC Capital Markets downgraded the shares of MAC in report on Wednesday, January 3 to “Sector Perform” rating. On Monday, July 18 the stock rating was maintained by Deutsche Bank with “Hold”. The stock has “Buy” rating by KeyBanc Capital Markets on Sunday, August 27. Boenning & Scattergood maintained the stock with “Hold” rating in Friday, August 4 report. The rating was downgraded by Goldman Sachs to “Sell” on Friday, March 17. As per Wednesday, August 23, the company rating was upgraded by Boenning & Scattergood. The rating was initiated by BTIG Research on Thursday, August 25 with “Buy”. RBC Capital Markets maintained Macerich Company (NYSE:MAC) rating on Tuesday, November 3. RBC Capital Markets has “Sector Perform” rating and $86 target. The firm earned “Neutral” rating on Monday, March 28 by Bank of America.

Ulysses Management Llc, which manages about $1.47 billion and $919.89 million US Long portfolio, decreased its stake in Goldman Sachs Group Inc (NYSE:GS) by 2,200 shares to 2,800 shares, valued at $664,000 in 2017Q3, according to the filing. It also reduced its holding in Discover Financial Services (NYSE:DFS) by 20,568 shares in the quarter, leaving it with 300,000 shares, and cut its stake in Republic First Bancorp Inc (NASDAQ:FRBK).

Analysts await Merit Medical Systems, Inc. (NASDAQ:MMSI) to report earnings on February, 20. They expect $0.32 EPS, up 3.23% or $0.01 from last year’s $0.31 per share. MMSI’s profit will be $16.07M for 36.89 P/E if the $0.32 EPS becomes a reality. After $0.32 actual EPS reported by Merit Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Frontier Capital Management Co Llc, which manages about $13.86 billion US Long portfolio, upped its stake in Gartner Inc. (NYSE:IT) by 5,376 shares to 427,567 shares, valued at $53.19M in 2017Q3, according to the filing. It also increased its holding in Macquarie Infrastructure Corporation (NYSE:MIC) by 175,638 shares in the quarter, for a total of 335,112 shares, and has risen its stake in Allegheny Technologies Incorporated (NYSE:ATI).

Investors sentiment decreased to 1.28 in Q3 2017. Its down 0.21, from 1.49 in 2017Q2. It dropped, as 14 investors sold MMSI shares while 71 reduced holdings. 44 funds opened positions while 65 raised stakes. 44.33 million shares or 0.69% more from 44.02 million shares in 2017Q2 were reported. Strs Ohio holds 0.01% or 28,100 shares in its portfolio. Verition Fund Mngmt Ltd accumulated 4,888 shares or 0.02% of the stock. 373,458 are owned by Comml Bank Of America De. State Common Retirement Fund reported 52,100 shares. Emerald Advisers Pa has 0.47% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 272,571 shares. X Lc holds 0% or 622 shares. Los Angeles Mngmt Equity owns 0% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 18,500 shares. Driehaus Capital Mngmt Ltd Liability holds 0.2% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 121,554 shares. Hbk Invests Ltd Partnership holds 0.01% or 17,142 shares. Amalgamated Commercial Bank stated it has 0.01% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Hancock Hldg invested in 29,500 shares. Wells Fargo And Com Mn holds 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 324,487 shares. Us Savings Bank De has 37,542 shares for 0.01% of their portfolio. State Of Tennessee Treasury Department reported 0.01% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). Missouri-based Amer Century Inc has invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI).

Among 8 analysts covering Merit Medical (NASDAQ:MMSI), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical had 18 analyst reports since October 23, 2015 according to SRatingsIntel. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) earned “Outperform” rating by Barrington Research on Monday, October 26. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) earned “Buy” rating by Canaccord Genuity on Tuesday, January 2. As per Thursday, July 27, the company rating was maintained by Canaccord Genuity. Craig Hallum maintained the stock with “Buy” rating in Thursday, July 27 report. Canaccord Genuity maintained Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday, November 16 with “Buy” rating. The company was maintained on Sunday, October 8 by Canaccord Genuity. The rating was initiated by Bank of America with “Buy” on Thursday, July 20. The rating was initiated by Canaccord Genuity on Tuesday, July 19 with “Buy”. The firm has “Buy” rating given on Monday, July 10 by Canaccord Genuity. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) has “Outperform” rating given on Monday, August 28 by Raymond James.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *